Can systemic and gut–pancreas axis inflammation impair exocrine pancreatic function?

Systemic inflammatory signaling and the bidirectional communication within the gut–pancreas axis are established drivers of exocrine pancreatic dysfunction. Evidence suggests that both systemic and localized intestinal inflammation can impair the synthesis, transport, and secretion of digestive enzymes, often leading to measurable declines in exocrine output.

Clinical and effectiveness evidence

Research consistently identifies a negative correlation between systemic inflammatory markers and pancreatic exocrine function.

• Biomarker Correlation: Clinical studies utilizing fecal elastase-1 (FE-1), a primary marker for pancreatic enzyme output, show that elevated inflammatory markers such as IL-6 and asprosin are associated with significantly lower FE-1 levels ($p < 0.05$).
• Inflammatory Conditions: In patients with Type 2 Diabetes and chronic inflammatory states, systemic cytokines are linked to subclinical pancreatic exocrine insufficiency (PEI).
• Gut-Related PEI: Secondary PEI is frequently observed in patients with intestinal inflammation, such as Inflammatory Bowel Disease (IBD) or Small Intestinal Bacterial Overgrowth (SIBO). Studies have demonstrated that treating the underlying gut inflammation (e.g., using rifaximin for SIBO) can restore FE-1 levels, indicating that the gut-pancreas axis directly modulates enzyme secretion.

Mechanistic explanations

The impairment of pancreatic function occurs through several distinct molecular and cellular pathways triggered by inflammatory signaling:

• Acinar Cell Stress: Pro-inflammatory cytokines like TNF-α, IL-6, and IL-1β induce endoplasmic reticulum (ER) stress and mitochondrial permeability transition pore (MPTP) opening in pancreatic acinar cells. This disrupts the metabolic capacity required for high-volume enzyme production.
• Calcium and Autophagy: Inflammation triggers intracellular calcium overload and impairs autophagy, which are critical for the healthy turnover and apical secretion of digestive zymogens.
• Gut-Pancreas Axis Signaling: Intestinal inflammation disrupts the vagovagal enteropancreatic reflex and hormonal triggers like cholecystokinin (CCK). Furthermore, the translocation of lipopolysaccharides (LPS) from an inflamed or "leaky" gut can activate Toll-like receptor 4 (TLR4) on pancreatic cells, inducing a localized inflammatory microenvironment that suppresses responsiveness to secretory signals.

Bottom line

Systemic and gut-centered inflammation significantly impair exocrine pancreatic function by inducing cellular stress in acinar cells and disrupting the hormonal/neural signals of the gut-pancreas axis. This often manifests as reduced digestive enzyme secretion and lower fecal elastase levels, which may improve upon resolving the underlying inflammatory state.